Archived App
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
Calculates survival probabilities for spine metastases at 30, 90, and 365 days. This tool is based on a validated prognostic algorithm for patients with metastatic spine disease.
What's New in SORG Spine Metastases Survival Calculator
1.0
April 20, 2017
This app has been updated by Apple to display the Apple Watch app icon.
Developer apps
FAQ
What is SORG Spine Metastases Survival Calculator used for?
SORG Spine Metastases Survival Calculator estimates survival probabilities for patients with spine metastases at 30, 90, and 365 days. It utilizes a prognostic algorithm developed from research published in J Bone Joint Surg Am.
What is the price of SORG Spine Metastases Survival Calculator?
SORG Spine Metastases Survival Calculator is available for a one-time purchase of $0.99.
What devices is SORG Spine Metastases Survival Calculator compatible with?
SORG Spine Metastases Survival Calculator is compatible with iPhone, iPad, and iPod touch devices.
What is the age rating for SORG Spine Metastases Survival Calculator?
SORG Spine Metastases Survival Calculator has an age rating of 4+, making it suitable for a wide range of users.
When was SORG Spine Metastases Survival Calculator last updated?
SORG Spine Metastases Survival Calculator was last updated on April 20, 2017, with version 1.0.
Who developed SORG Spine Metastases Survival Calculator?
SORG Spine Metastases Survival Calculator was developed by Healthcare Technologies LLC.
Does SORG Spine Metastases Survival Calculator have ads?
The provided data does not indicate whether SORG Spine Metastases Survival Calculator contains advertisements. However, as it is a paid application, it is unlikely to feature ads.
How accurate is SORG Spine Metastases Survival Calculator?
The calculator is based on a validated prognostic survival algorithm for patients with metastatic spine disease, as published in J Bone Joint Surg Am. The app has a 5.0-star rating from one user review.
